|Last Price$6.27||Day Change (%)2.28%|
|Open Price$6.10||Day Change ($)0.14|
|Day Range6.05–6.30||52-Week Range4.33–8.41|
As of Fri 03/14/2014 03:41 PM EST | USD
William D. Young To Retire From Biogen Idec’s Board of Directors
Lack of competitive advantages may mean these companies aren't the bargains they seem to be.
We see opportunity as fleeing investors trigger an irrational sell-off.
Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.
The five biotech ETFs have very different portfolios with markedly different performance.